4//SEC Filing
Reininger Cornelia 4
Accession 0001225208-13-004548
CIK 0000810509other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:49 PM ET
Size
5.1 KB
Accession
0001225208-13-004548
Insider Transaction Report
Form 4
Reininger Cornelia
SVP & Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2013-02-15+120,000→ 120,000 totalExercise: $3.08Exp: 2023-02-15→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]Option vests 25% per year beginning on the first anniversary of the date of grant.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeother
Related Parties
1- filerCIK 0001559878
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:49 PM ET
- Size
- 5.1 KB